Clinical trials
Coronary Artery Disease trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
61 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 4 |
| 2011 | 4 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 6 |
| 2023 | 5 |
| 2024 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 36 |
| Unknown status | 6 |
| Recruiting | 6 |
| Active, not recruiting | 6 |
| Terminated | 3 |
| Suspended | 2 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abbott Medical Devices | 7 |
| Sahajanand Medical Technologies Limited | 4 |
| MDDX LLC | 3 |
| Meenakshi Ammal Dental College and Hospital | 3 |
| Seung-Jung Park | 3 |
| AstraZeneca | 2 |
| Biotronik AG | 2 |
| Meril Life Sciences Pvt. Ltd. | 2 |
| NYU Langone Health | 2 |
| Novartis Pharmaceuticals | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 61 |
| Myocardial Ischemia | 10 |
| Coronary Disease | 8 |
| Coronary Stenosis | 8 |
| Cardiovascular Diseases | 7 |
| Heart Diseases | 6 |
| Vascular Diseases | 6 |
| Coronary Restenosis | 5 |
| Acute Coronary Syndrome | 4 |
| Diabetes Mellitus, Type 2 | 4 |
Trials
Showing 51 to 61 of 61. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.